Gyre Therapeutics, Inc. (NASDAQ:GYRE) currently has 45 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 1,201,589 | 51,030 | 4.44% | $8,483,219.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 720,291 | 60,894 | 9.23% | $5,085,254.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 423,222 | 48,602 | 12.97% | $2,988,936.00 |
| STATE STREET CORP | 31 Dec, 2025 | 202,225 | 19,472 | 10.65% | $1,427,709.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 169,158 | 45,772 | 37.10% | $1,194,255.00 |
| SBI Securities Co., Ltd. | 31 Dec, 2025 | 162,915 | -4,951 | -2.95% | $1,150,180.00 |
| NORTHERN TRUST CORP | 31 Dec, 2025 | 128,855 | 12,513 | 10.76% | $909,716.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 54,498 | 45,517 | 506.81% | $384,757.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 41,203 | 16,805 | 68.88% | $290,894.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 31,108 | 13,074 | 72.50% | $219,622.00 |
| STATE OF WISCONSIN INVESTMENT BOARD | 31 Dec, 2025 | 24,800 | -14,200 | -36.41% | $175,088.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 21,830 | 0 | 0.00% | $154,120.00 |
| STRS OHIO | 31 Dec, 2025 | 21,100 | 0 | 0.00% | $148,966.00 |
| BARCLAYS PLC | 31 Dec, 2025 | 18,531 | 5,135 | 38.33% | $130,829.00 |
| RHUMBLINE ADVISERS | 31 Dec, 2025 | 14,032 | 600 | 4.47% | $99,057.00 |
| WELLS FARGO & COMPANY/MN | 31 Dec, 2025 | 12,919 | 7,361 | 132.44% | $91,208.00 |
| ROYAL BANK OF CANADA | 31 Dec, 2025 | 12,765 | 370 | 2.99% | $91,000.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 10,903 | 10,903 | 0.00% | $76,975.00 |
| DEUTSCHE BANK AG\ | 31 Dec, 2025 | 10,613 | -314 | -2.87% | $74,928.00 |
| FMR LLC | 31 Dec, 2025 | 10,304 | 100 | 0.98% | $72,746.00 |